SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-130258
Filing Date
2011-05-06
Accepted
2011-05-06 13:14:41
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 367579
2 FIFTH AMENDMENT TO LEASE BETWEEN TBCI, LLC AND AGENUS, INC. dex103.htm EX-10.3 30196
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9429
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9429
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4676
  Complete submission text file 0001193125-11-130258.txt   422397
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 11818249
SIC: 2836 Biological Products, (No Diagnostic Substances)